CMKLR1 antagonist 1 (compound S-26d) is a potent, orally active antagonist of the chemokine-like receptor 1 (CMKLR1) with a pIC50 of 7.44 in hCMKLR1-transfected CHO cells, applicable in the research of psoriasis and metabolic diseases [1].
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted